ArticleNature immunology2025

Efficacy of CTLA-4 checkpoint therapy is dependent on IL-21 signaling to mediate cytotoxic reprogramming of PD-1

Zhen Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.